Clinical, Cosmetic and Investigational Dermatology《临床、美容与研究性皮肤病》(可官网投稿)

Clinical, Cosmetic and Investigational Dermatology《临床、美容与研究性皮肤病》(不定期). Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions.

杂志简称:clin cosmet inv derm
中文译名:《临床、美容与研究性皮肤病》
收录属性:scie(2024版), 目次收录(知网),英文期刊,
自引率:3.70%
投稿方向:医学、dermatology皮肤病学

Clinical, Cosmetic and Investigational Dermatology《临床、美容与研究性皮肤病》

SCI/E期刊基本信息

出版周期:不定期 地区:新西兰
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:OA期刊
国际标准刊号:ISSN 1178-7015;EISSN 1178-7015
杂志语言:英语
出版国家:新西兰

杂志官网 联系方式

出版地址:PO BOX 300-008,ALBANY,NEW ZEALAND,AUCKLAND,0752
杂志邮箱:
投稿网址:https://www.dovepress.com/submit-step-1.php
杂志官方网址:https://www.dovepress.com/journal-editor-clinical-cosmetic-and-investigational-dermatology-eic33
出版商网址:http://www.dovepress.com

杂志投稿要求

期刊信息【杂志社官方网站信息】

Clinical, Cosmetic and Investigational Dermatology

Aims and Scope

Clinical, Cosmetic and Investigational Dermatology is an international, peer-reviewed, open access journal that focuses on the latest clinical and experimental research in all aspects of skin disease and cosmetic interventions.

Meta-analyses will no longer be considered for publication.

Specific topics covered by the journal include:

Normal and pathological processes in skin development and aging, their modification and treatment

Basic research into histology of dermal structures

Clinical insights and potential treatment options

Patient satisfaction, preference, quality of life, compliance

Development of new management options to optimize outcomes for target conditions

The journal is characterized by the rapid reporting of clinical studies, reviews and original research in skin research and skin care.

Call For Papers

o see where Clinical, Cosmetic and Investigational Dermatology is indexed online view the Journal Metrics.

What is the advantage to you of publishing in Clinical, Cosmetic and Investigational Dermatology?

It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.

Although Clinical, Cosmetic and Investigational Dermatology receives a lot of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.

The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Clinical, Cosmetic and Investigational Dermatology has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.

Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.

PubMed Central

Clinical, Cosmetic and Investigational Dermatology is indexed on PubMed Central (title abbreviation: Clin Cosmet Investig Dermatol). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits

If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.

Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.

Yours sincerely

Dr Jeffrey M. Weinberg

Editor-in-Chief

Clinical, Cosmetic and Investigational Dermatology

Email: Editor-in-Chief

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/43613

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 下午12:01
下一篇 2024年11月9日 下午12:01

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息